These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23363553)

  • 1. An update of "Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model".
    Tu HA; Rozenbaum MH; de Boer PT; Noort AC; Postma MJ
    BMC Infect Dis; 2013 Jan; 13():54. PubMed ID: 23363553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of a pentavalent rotavirus vaccine in Oman.
    Al Awaidy ST; Gebremeskel BG; Al Obeidani I; Al Baqlani S; Haddadin W; O'Brien MA
    BMC Infect Dis; 2014 Jun; 14():334. PubMed ID: 24941946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model.
    Rozenbaum MH; Mangen MJ; Giaquinto C; Wilschut JC; Hak E; Postma MJ;
    BMC Public Health; 2011 Jun; 11():462. PubMed ID: 21663620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.
    Bar-Zeev N; Tate JE; Pecenka C; Chikafa J; Mvula H; Wachepa R; Mwansambo C; Mhango T; Chirwa G; Crampin AC; Parashar UD; Costello A; Heyderman RS; French N; Atherly D; Cunliffe NA;
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S220-8. PubMed ID: 27059360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe".
    Jit M; Mangen MJ; Melliez H; Yazdanpanah Y; Bilcke J; Salo H; Edmunds WJ; Beutels P
    Vaccine; 2010 Nov; 28(47):7457-9. PubMed ID: 20846529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of childhood rotavirus vaccination in Germany.
    Aidelsburger P; Grabein K; Böhm K; Dietl M; Wasem J; Koch J; Ultsch B; Weidemann F; Wichmann O
    Vaccine; 2014 Apr; 32(17):1964-74. PubMed ID: 24561052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of a pentavalent rotavirus vaccine in Japan.
    Itzler R; O'Brien MA; Yamabe K; Abe M; Dhankhar P
    J Med Econ; 2013 Oct; 16(10):1216-27. PubMed ID: 23919721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia.
    Reyes JF; Wood JG; Beutels P; Macartney K; McIntyre P; Menzies R; Mealing N; Newall AT
    Vaccine; 2017 Jan; 35(2):345-352. PubMed ID: 27916411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.
    Atkins KE; Shim E; Carroll S; Quilici S; Galvani AP
    Vaccine; 2012 Nov; 30(48):6766-76. PubMed ID: 23000223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
    Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
    Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense?
    Rheingans RD; Heylen J; Giaquinto C
    Pediatr Infect Dis J; 2006 Jan; 25(1 Suppl):S48-55. PubMed ID: 16397429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.
    Freiesleben de Blasio B; Flem E; Latipov R; Kuatbaeva A; Kristiansen IS
    Emerg Infect Dis; 2014 Jan; 20(1):29-37. PubMed ID: 24378188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An economic analysis of rotavirus vaccination in Italy.
    Giammanco MD; Coniglio MA; Pignato S; Giammanco G
    Vaccine; 2009 Jun; 27(29):3904-11. PubMed ID: 19446934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
    Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination.
    Bruijning-Verhagen P; Mangen MJ; Felderhof M; Hartwig NG; van Houten M; Winkel L; de Waal WJ; Bonten MJ
    BMC Med; 2013 Apr; 11():112. PubMed ID: 23622110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.
    Tilson L; Jit M; Schmitz S; Walsh C; Garvey P; McKeown P; Barry M
    Vaccine; 2011 Oct; 29(43):7463-73. PubMed ID: 21821085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of rotavirus vaccination programs in Taiwan.
    Chang WC; Yen C; Chi CL; Wu FT; Huang YC; Lin JS; Huang FC; Tate JE; Wu HS; Hsiung CA
    Vaccine; 2013 Nov; 31(46):5458-65. PubMed ID: 24060569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation.
    Fisman DN; Chan CH; Lowcock E; Naus M; Lee V
    Vaccine; 2012 Dec; 30(52):7601-7. PubMed ID: 23107595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule.
    Milne RJ; Grimwood K
    Value Health; 2009 Sep; 12(6):888-98. PubMed ID: 19490550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of rotavirus vaccination in Turkey.
    Koksal T; Akelma AZ; Koksal AO; Kutukoglu I; Ozdemir O; Yuksel CN; Bozkaya D; Catal F; Sari S
    J Microbiol Immunol Infect; 2017 Oct; 50(5):693-699. PubMed ID: 27107612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.